Please login to the form below

Not currently logged in

personal health monitoring

This page shows the latest personal health monitoring news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • A cultural shift in clinical research A cultural shift in clinical research

    Similarly, telemedicine is now frequently used for routine patient monitoring and follow-ups, particularly in phase 1 studies. ... Essentially, these devices (usually worn on the wrist) acts as personal assistants, monitoring patients’ health status

  • From measurement to management From measurement to management

    It is now universally recognised by leading health organisations that it is important to focus on 'wellness' rather than deal only with illness. ... see above), due in large part, to the growth and accessibility of online health information and the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The Future of eHealth: Contactless Health Monitoring

    Laurence Pearce, CEO &Founder of Xim Ltd, creators of Lifelight, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer vision in

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....